T

The Duke Human Vaccine Institute

198 employees

DHIV develops novel vaccines and therapeutics and diagnosis for t infectious diseases that impact global health.

Basic info

Industry

research services

Sectors

Biotechnology
Health Diagnostics
Innovative Diagnostics
Health Care
Global Health
Infectious Diseases
Medical
Vaccines and Therapeutics

Date founded

1990

Funding rounds raised

Total raised

$26M

from 2 investors over 2 rounds

T

The Duke Human Vaccine Institute raised $26M on October 11, 2022

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

T

The Duke Human Vaccine Institute raised $18M on October 21, 2021

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

FAQ